Mercer Global Advisors Inc Pacira Bio Sciences, Inc. Transaction History
Mercer Global Advisors Inc
- $39.5 Billion
- Q2 2024
A detailed history of Mercer Global Advisors Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 12,686 shares of PCRX stock, worth $209,572. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,686
Previous 9,124
39.04%
Holding current value
$209,572
Previous $267,000
35.58%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PCRX
# of Institutions
302Shares Held
51.6MCall Options Held
378KPut Options Held
1.53M-
Black Rock Inc. New York, NY8.01MShares$132 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$84 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.16MShares$35.7 Million0.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.07MShares$34.1 Million0.1% of portfolio
-
State Street Corp Boston, MA1.9MShares$31.5 Million0.0% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $757M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...